EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Targeting Cancer Cell Proliferation Using Piperazine‐Linked Quinolinequinones: Mechanism and Metabolic Profile

Ayse Mine Yilmaz iD, Ayse Tarbin Jannuzzi iD, Abanish Biswas, Subodh Mondal, Vinay N Basavanakatti, Hatice Yıldırım iD, Mahmut Yıldız, Nilüfer Bayrak, Venkatesan Jayaprakash, Amaç Fatih TuYuN iD

Chemical Biology & Drug Design · 2025

DOI: 10.1111/cbdd.70139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2025. Verfasst von Ayse Mine Yilmaz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, School of Medicine/Genetic and Metabolic Diseases Research and Investigation Center, Marmara University, Istanbul, Türkiy…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Piperazines, Quinolines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of aminated quinolinequinones linked to piperazine analogs ( QQ1‐7 ) were synthesized and screened against the full panel of National Cancer Institute (NCI) cancer cell lines for their potential as cytotoxic agents. The Developmental Therapeutics Program of the NCI analyzed the NCI‐60 screening results and revealed that seven QQs were potent inhibitors of cancer cell growth across several cell lines, advancing them to the five‐dose assay. Encouraged by the NCI five‐dose assay results, the cytotoxicity of the selected QQs ( QQ1 and QQ4 ) was further studied in three cancer cell lines—HCT‐116 (colon cancer), ACHN (renal cancer), MCF7, and T‐47D (breast cancer)—as well as in a normal cell line (HUVEC) for a deeper understanding. QQ1 was the hit compound for ACHN cells with an IC 50 value of 1.55 μM. QQ1 could inhibit ACHN cell proliferation, induce oxidative stress, and cause cell cycle arrest in ACHN cells. QQ1 did not affect the apoptotic value in ACHN cells. Oral bioavailability was poor for both QQ1 and QQ4 in vivo in rats due to faster intrinsic hepatic clearance in comparison with humans, as evidenced by in vitro metabolic studies with rat and human liver microsomes. Molecular docking simulation with putative target CDC25A revealed the interaction of QQ1 and QQ4 with active site residues responsible for substrate recognition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsPiperazinesQuinolinesHumansCell ProliferationCell Line, TumorMolecular Docking SimulationAnimalsRatsRats, Sprague-DawleyApoptosisDrug Screening Assays, AntitumorMalePiperazineOxidative StressMicrosomes, Liver

Stichwörter der Autor:innen

ADMEbreast cancercolon cancercytotoxicitymolecular dynamicsrenal cancer

Substanzen

Antineoplastic AgentsPiperazinesQuinolinesPiperazine

Autor:innen und Institutionen

  • Department of Biochemistry, School of Medicine/Genetic and Metabolic Diseases Research and Investigation Center, Marmara University, Istanbul, Türkiye.
  • Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Istanbul University, Istanbul, Türkiye.
  • Department of Pharmaceutical Sciences & Technology, Birla Institute of Technology, Ranchi, Jharkhand, India.
  • Bioanalysis, Eurofins Advinus BioPharma Services India Pvt Ltd., Bengaluru, Karnataka, India.
  • Adgyl Lifesciences Private Limited, Bengaluru, Karnataka, India.
  • Department of Chemistry, Engineering Faculty, Istanbul University-Cerrahpasa, Istanbul, Türkiye.

ORCID-Profile: Ayse Mine Yilmaz, Ayse Tarbin Jannuzzi, Hatice Yıldırım, Amaç Fatih TuYuN

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Yilmaz, A. M., Jannuzzi, A. T., Biswas, A., Mondal, S., Basavanakatti, V. N., Yıldırım, H., Yıldız, M., Bayrak, N., Jayaprakash, V., & TuYuN, A. F. (2025). Targeting Cancer Cell Proliferation Using Piperazine‐Linked Quinolinequinones: Mechanism and Metabolic Profile. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70139

Vancouver

Yilmaz AM, Jannuzzi AT, Biswas A, Mondal S, Basavanakatti VN, Yıldırım H, et al. Targeting Cancer Cell Proliferation Using Piperazine‐Linked Quinolinequinones: Mechanism and Metabolic Profile. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70139

BibTeX
@article{Yilmaz2025,
  author = {Yilmaz, Ayse Mine and Jannuzzi, Ayse Tarbin and Biswas, Abanish and Mondal, Subodh and Basavanakatti, Vinay N and Yıldırım, Hatice and Yıldız, Mahmut and Bayrak, Nilüfer and Jayaprakash, Venkatesan and TuYuN, Amaç Fatih},
  title = {Targeting Cancer Cell Proliferation Using Piperazine‐Linked Quinolinequinones: Mechanism and Metabolic Profile},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  doi = {10.1111/cbdd.70139}
}
Kostenlos starten →